Correction to CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus

IF 11.4 1区医学 Q1 RHEUMATOLOGY

Arthritis & Rheumatology Pub Date : 2025-01-31 DOI:10.1002/art.43080

引用次数: 0

Abstract

Correction to “Figure 3. Key insights from CAR T cell therapy in SLE.”

Arthritis & Rheumatology

Vol. 76, No. 4, April 2024, pp 497–504

DOI 10.1002/art.42784

In the middle panel of this figure, the plasma cells are identified as “CD19+CD20-” (same as the plasmablasts) – but one key point of the paper is that they are not CD19+. It should read “CD19– CD20–”.

Also, in the same panel and figure, measles is misspelled as “measels.”

Please see below for the corrected version of this figure.

We apologize for this error.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Arthritis & Rheumatology RHEUMATOLOGY-

CiteScore

20.90

自引率

3.00%

发文量

371

期刊介绍： Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.